Loss of Cortical Actin Filaments in Insulin-resistant Skeletal Muscle Cells Impairs GLUT4 Vesicle Trafficking and Glucose Transport
Overview
Physiology
Affiliations
Study has demonstrated an essential role of cortical filamentous actin (F-actin) in insulin-regulated glucose uptake by skeletal muscle. Here, we tested whether perturbations in F-actin contributed to impaired insulin responsiveness provoked by hyperinsulinemia. In L6 myotubes stably expressing GLUT4 that carries an exofacial myc-epitope tag, acute insulin stimulation (20 min, 100 nM) increased GLUT4myc translocation and glucose uptake by approximately 2-fold. In contrast, a hyperinsulinemic state, induced by inclusion of 5 nM insulin in the medium for 12 h decreased the ability of insulin to stimulate these processes. Defects in insulin signaling did not readily account for the observed disruption. In contrast, hyperinsulinemia reduced cortical F-actin. This occurred concomitant with a loss of plasma membrane phosphatidylinositol 4,5-bisphosphate (PIP(2)), a lipid involved in cytoskeletal regulation. Restoration of plasma membrane PIP(2) in hyperinsulinemic cells restored F-actin and insulin responsiveness. Consistent with these in vitro observations suggesting that the hyperinsulinemic state negatively affects cortical F-actin structure, epitrochlearis skeletal muscle from insulin-resistant hyperinsulinemic Zucker fatty rats displayed a similar loss of F-actin structure compared with that in muscle from lean insulin-sensitive littermates. We propose that a component of insulin-induced insulin resistance in skeletal muscle involves defects in PIP(2)/F-actin structure essential for insulin-regulated glucose transport.
Balakrishnan R, Garcia P, Veluthakal R, Huss J, Hoolachan J, Thurmond D Antioxidants (Basel). 2023; 12(9).
PMID: 37759961 PMC: 10525748. DOI: 10.3390/antiox12091658.
Insulin signalling and GLUT4 trafficking in insulin resistance.
van Gerwen J, Shun-Shion A, Fazakerley D Biochem Soc Trans. 2023; 51(3):1057-1069.
PMID: 37248992 PMC: 10317183. DOI: 10.1042/BST20221066.
Merz K, Tunduguru R, Ahn M, Salunkhe V, Veluthakal R, Hwang J Front Endocrinol (Lausanne). 2022; 13:821849.
PMID: 35222279 PMC: 8881144. DOI: 10.3389/fendo.2022.821849.
Henriquez-Olguin C, Boronat S, Cabello-Verrugio C, Jaimovich E, Hidalgo E, Jensen T Antioxid Redox Signal. 2019; 31(18):1371-1410.
PMID: 31588777 PMC: 6859696. DOI: 10.1089/ars.2018.7678.
Grice B, Barton K, Covert J, Kreilach A, Tackett L, Brozinick J Am J Physiol Endocrinol Metab. 2019; 317(2):E362-E373.
PMID: 31237447 PMC: 6732462. DOI: 10.1152/ajpendo.00396.2018.